Process View
Any process that modulates the frequency, rate or extent of response to oxidative stress.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "regulation of response to oxidative stress"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| BCL2L11 | BCL2-like 11 (apoptosis facilitator) | 0.902 | ||
| BCL2L1 | BCL2-like 1 | 0.814 | Human | |
| MAFG | v-maf musculoaponeurotic fibrosarcoma oncogene homolog G (avian) | 0.586 | ||
| TRIB3 | tribbles homolog 3 (Drosophila) | 0.525 | ||
| EGFR | epidermal growth factor receptor | 0.436 | ||
| PRDX1 | peroxiredoxin 1 | 0.404 | ||
| SNTA1 | syntrophin, alpha 1 (dystrophin-associated protein A1, 59kDa, acidic component) | 0.350 | ||
| SQSTM1 | sequestosome 1 | 0.314 | ||
| INSR | insulin receptor | 0.281 | Worm | |
| BID | BH3 interacting domain death agonist | 0.266 | ||
| GAS6 | growth arrest-specific 6 | 0.262 | ||
| MAPT | microtubule-associated protein tau | 0.206 | ||
| BCL2 | B-cell CLL/lymphoma 2 | 0.195 | Human | |
| MCL1 | myeloid cell leukemia sequence 1 (BCL2-related) | 0.188 | ||
| BAK1 | BCL2-antagonist/killer 1 | 0.185 | Human | |
| WBP4 | WW domain binding protein 4 (formin binding protein 21) | 0.175 | ||
| BAD | BCL2-associated agonist of cell death | 0.168 | ||
| DYNLL1 | dynein, light chain, LC8-type 1 | 0.153 | ||
| SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.152 | ||
| IRS1 | insulin receptor substrate 1 | 0.137 | ||
| PML | promyelocytic leukemia | 0.137 | ||
| APOE | apolipoprotein E | 0.136 | ||
| CSNK1A1 | casein kinase 1, alpha 1 | 0.130 | ||
| HIF1A | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 0.127 | ||
| PINK1 | PTEN induced putative kinase 1 | 0.127 | ||
| FBXO7 | F-box protein 7 | 0.098 | ||
| PARK2 | parkinson protein 2, E3 ubiquitin protein ligase (parkin) | 0.096 | ||
| KEAP1 | kelch-like ECH-associated protein 1 | 0.095 | ||
| BAX | BCL2-associated X protein | 0.095 | Human | |
| UBE3A | ubiquitin protein ligase E3A | 0.093 | ||
| DDIT3 | DNA-damage-inducible transcript 3 | 0.092 | ||
| GAB1 | GRB2-associated binding protein 1 | 0.088 | ||
| NFE2L2 | nuclear factor (erythroid-derived 2)-like 2 | 0.087 | ||
| DAXX | death-domain associated protein | 0.086 | ||
| SFPQ | splicing factor proline/glutamine-rich | 0.084 | ||
| BAG3 | BCL2-associated athanogene 3 | 0.078 | ||
| ZNF746 | zinc finger protein 746 | 0.072 | ||
| TOP1 | topoisomerase (DNA) I | 0.066 | ||
| CRYAB | crystallin, alpha B | 0.065 | ||
| IRS2 | insulin receptor substrate 2 | 0.065 | ||
| GSK3B | glycogen synthase kinase 3 beta | 0.065 | ||
| NONO | non-POU domain containing, octamer-binding | 0.064 | ||
| VHL | von Hippel-Lindau tumor suppressor | 0.061 | ||
| NAMPT | nicotinamide phosphoribosyltransferase | 0.061 | ||
| RNR2 | l-rRNA | 0.058 | ||
| MAP2K5 | mitogen-activated protein kinase kinase 5 | 0.057 | ||
| ARNT | aryl hydrocarbon receptor nuclear translocator | 0.055 | ||
| HSPB8 | heat shock 22kDa protein 8 | 0.053 | ||
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.052 | ||
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.052 | ||
| CPNE6 | copine VI (neuronal) | 0.051 | ||
| NCOR2 | nuclear receptor corepressor 2 | 0.051 | ||
| LOXL1 | lysyl oxidase-like 1 | 0.048 | ||
| IGF1R | insulin-like growth factor 1 receptor | 0.048 | Worm | |
| APOA1 | apolipoprotein A-I | 0.047 | ||
| SNCAIP | synuclein, alpha interacting protein | 0.046 | ||
| EGLN1 | egl nine homolog 1 (C. elegans) | 0.045 | ||
| DUSP1 | dual specificity phosphatase 1 | 0.044 | ||
| LTBP2 | latent transforming growth factor beta binding protein 2 | 0.044 | ||
| FTL | ferritin, light polypeptide | 0.043 | ||
| RNF144B | ring finger protein 144B | 0.043 | ||
| SNCA | synuclein, alpha (non A4 component of amyloid precursor) | 0.042 | ||
| MAFF | v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) | 0.042 | ||
| TGIF1 | TGFB-induced factor homeobox 1 | 0.040 | ||
| HDAC1 | histone deacetylase 1 | 0.039 | ||
| GRB10 | growth factor receptor-bound protein 10 | 0.039 | ||
| ARHGEF7 | Rho guanine nucleotide exchange factor (GEF) 7 | 0.035 | ||
| MAP2K6 | mitogen-activated protein kinase kinase 6 | 0.035 | ||
| PLAU | plasminogen activator, urokinase | 0.034 | Human | |
| MAPK14 | mitogen-activated protein kinase 14 | 0.033 | Fly | |
| PRDX4 | peroxiredoxin 4 | 0.033 | ||
| CCDC6 | coiled-coil domain containing 6 | 0.032 | ||
| PDIA4 | protein disulfide isomerase family A, member 4 | 0.032 | ||
| PLXNB1 | plexin B1 | 0.032 | ||
| PDIA3 | protein disulfide isomerase family A, member 3 | 0.031 | ||
| APLP2 | amyloid beta (A4) precursor-like protein 2 | 0.031 | ||
| HSPA1B | heat shock 70kDa protein 1B | 0.030 | ||
| ERO1L | ERO1-like (S. cerevisiae) | 0.030 | ||
| CALR | calreticulin | 0.030 | ||
| FTH1 | ferritin, heavy polypeptide 1 | 0.029 | ||
| SIN3A | SIN3 homolog A, transcription regulator (yeast) | 0.029 | ||
| EFTUD2 | elongation factor Tu GTP binding domain containing 2 | 0.029 | ||
| CEBPB | CCAAT/enhancer binding protein (C/EBP), beta | 0.028 | ||
| YWHAE | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide | 0.028 | ||
| BACH1 | BTB and CNC homology 1, basic leucine zipper transcription factor 1 | 0.028 | Human | |
| PRKCA | protein kinase C, alpha | 0.028 | ||
| APP | amyloid beta (A4) precursor protein | 0.027 | ||
| RAB5B | RAB5B, member RAS oncogene family | 0.026 | ||
| LRRK2 | leucine-rich repeat kinase 2 | 0.025 | ||
| GHR | growth hormone receptor | 0.025 | ||
| FAS | Fas (TNF receptor superfamily, member 6) | 0.025 | ||
| MMS22L | MMS22-like, DNA repair protein | 0.025 | ||
| APOH | apolipoprotein H (beta-2-glycoprotein I) | 0.024 | ||
| HM13 | histocompatibility (minor) 13 | 0.024 | ||
| MEF2C | myocyte enhancer factor 2C | 0.024 | ||
| POLR2C | polymerase (RNA) II (DNA directed) polypeptide C, 33kDa | 0.024 | ||
| CUL7 | cullin 7 | 0.023 | ||
| NOG | noggin | 0.023 | ||
| BANP | BTG3 associated nuclear protein | 0.023 | ||
| SOCS3 | suppressor of cytokine signaling 3 | 0.022 | ||
| ADRBK1 | adrenergic, beta, receptor kinase 1 | 0.022 | ||
| PPIB | peptidylprolyl isomerase B (cyclophilin B) | 0.022 | ||
| STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) | 0.022 | ||
| CDK2AP2 | cyclin-dependent kinase 2 associated protein 2 | 0.022 | ||
| LRP6 | low density lipoprotein receptor-related protein 6 | 0.022 | ||
| AHR | aryl hydrocarbon receptor | 0.021 | ||
| MAX | MYC associated factor X | 0.021 | ||
| LAT | linker for activation of T cells | 0.020 | ||
| CTSD | cathepsin D | 0.020 | ||
| ZBED1 | zinc finger, BED-type containing 1 | 0.020 | ||
| GAB2 | GRB2-associated binding protein 2 | 0.020 | ||
| CTSL1 | cathepsin L1 | 0.020 | ||
| DBN1 | drebrin 1 | 0.020 | ||
| MAPK6 | mitogen-activated protein kinase 6 | 0.019 | ||
| NCL | nucleolin | 0.019 | ||
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.019 | ||
| HUWE1 | HECT, UBA and WWE domain containing 1 | 0.019 | ||
| RANBP9 | RAN binding protein 9 | 0.018 | ||
| KNG1 | kininogen 1 | 0.018 | ||
| MAPKAPK3 | mitogen-activated protein kinase-activated protein kinase 3 | 0.018 | ||
| RIPK2 | receptor-interacting serine-threonine kinase 2 | 0.018 | ||
| DUSP23 | dual specificity phosphatase 23 | 0.017 | ||
| CARS | cysteinyl-tRNA synthetase | 0.017 | ||
| DYNLT1 | dynein, light chain, Tctex-type 1 | 0.017 | ||
| MAP1LC3B | microtubule-associated protein 1 light chain 3 beta | 0.017 | ||
| ARHGEF12 | Rho guanine nucleotide exchange factor (GEF) 12 | 0.017 | ||
| JAK2 | Janus kinase 2 | 0.016 | ||
| SYVN1 | synovial apoptosis inhibitor 1, synoviolin | 0.016 | ||
| MAP1B | microtubule-associated protein 1B | 0.016 | ||
| TBC1D14 | TBC1 domain family, member 14 | 0.016 | ||
| PTPRJ | protein tyrosine phosphatase, receptor type, J | 0.016 | ||
| NFIL3 | nuclear factor, interleukin 3 regulated | 0.016 | ||
| OBSL1 | obscurin-like 1 | 0.016 | ||
| EIF2S3 | eukaryotic translation initiation factor 2, subunit 3 gamma, 52kDa | 0.016 | ||
| HNRNPK | heterogeneous nuclear ribonucleoprotein K | 0.016 | ||
| BIRC3 | baculoviral IAP repeat containing 3 | 0.015 | ||
| SAT1 | spermidine/spermine N1-acetyltransferase 1 | 0.015 | ||
| MMP1 | matrix metallopeptidase 1 (interstitial collagenase) | 0.015 | ||
| HSPB2 | heat shock 27kDa protein 2 | 0.015 | ||
| SERPINC1 | serpin peptidase inhibitor, clade C (antithrombin), member 1 | 0.015 | ||
| PRKCZ | protein kinase C, zeta | 0.015 | ||
| GANAB | glucosidase, alpha; neutral AB | 0.015 | ||
| WASF1 | WAS protein family, member 1 | 0.015 | ||
| EGLN3 | egl nine homolog 3 (C. elegans) | 0.015 | ||
| RUNX1 | runt-related transcription factor 1 | 0.014 | ||
| ZFYVE9 | zinc finger, FYVE domain containing 9 | 0.014 | ||
| FUS | fused in sarcoma | 0.014 | ||
| NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 0.014 | ||
| IL8 | interleukin 8 | 0.014 | ||
| GCH1 | GTP cyclohydrolase 1 | 0.014 | ||
| KAT2B | K(lysine) acetyltransferase 2B | 0.014 | ||
| WTAP | Wilms tumor 1 associated protein | 0.014 | ||
| CELSR1 | cadherin, EGF LAG seven-pass G-type receptor 1 (flamingo homolog, Drosophila) | 0.014 | ||
| UBASH3B | ubiquitin associated and SH3 domain containing B | 0.014 | ||
| SDCBP | syndecan binding protein (syntenin) | 0.014 | ||
| SLC1A2 | solute carrier family 1 (glial high affinity glutamate transporter), member 2 | 0.013 | ||
| MAPK11 | mitogen-activated protein kinase 11 | 0.013 | Fly | |
| PRDX6 | peroxiredoxin 6 | 0.013 | ||
| MAFK | v-maf musculoaponeurotic fibrosarcoma oncogene homolog K (avian) | 0.013 | ||
| PRDX2 | peroxiredoxin 2 | 0.013 | ||
| RNF11 | ring finger protein 11 | 0.013 | ||
| ACSL1 | acyl-CoA synthetase long-chain family member 1 | 0.013 | ||
| CYLD | cylindromatosis (turban tumor syndrome) | 0.013 | ||
| CMIP | c-Maf-inducing protein | 0.013 | ||
| TIMP2 | TIMP metallopeptidase inhibitor 2 | 0.013 | ||
| PLAUR | plasminogen activator, urokinase receptor | 0.013 | ||
| HSPA1A | heat shock 70kDa protein 1A | 0.013 | ||
| UBQLN1 | ubiquilin 1 | 0.013 | ||
| DUSP9 | dual specificity phosphatase 9 | 0.013 | ||
| WBP2 | WW domain binding protein 2 | 0.012 | ||
| PMAIP1 | phorbol-12-myristate-13-acetate-induced protein 1 | 0.012 | ||
| RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.012 | ||
| GAPDH | glyceraldehyde-3-phosphate dehydrogenase | 0.012 | ||
| APLP1 | amyloid beta (A4) precursor-like protein 1 | 0.012 | ||
| TPPP | tubulin polymerization promoting protein | 0.012 | ||
| NCOA6 | nuclear receptor coactivator 6 | 0.012 | ||
| CDK12 | cyclin-dependent kinase 12 | 0.012 | ||
| GFER | growth factor, augmenter of liver regeneration | 0.012 | ||
| CEBPG | CCAAT/enhancer binding protein (C/EBP), gamma | 0.012 | ||
| EPAS1 | endothelial PAS domain protein 1 | 0.012 | Human | |
| PACRG | PARK2 co-regulated | 0.012 | ||
| ATF5 | activating transcription factor 5 | 0.012 | Human | |
| ARNTL | aryl hydrocarbon receptor nuclear translocator-like | 0.012 | ||
| MAPKAPK2 | mitogen-activated protein kinase-activated protein kinase 2 | 0.012 | ||
| ENO1 | enolase 1, (alpha) | 0.012 | ||
| CREBBP | CREB binding protein | 0.012 | ||
| VEGFA | vascular endothelial growth factor A | 0.011 | ||
| HNRNPU | heterogeneous nuclear ribonucleoprotein U (scaffold attachment factor A) | 0.011 | ||
| OS9 | osteosarcoma amplified 9, endoplasmic reticulum lectin | 0.011 | ||
| PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.011 | ||
| KIT | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | 0.011 | ||
| EZR | ezrin | 0.011 | ||
| MYC | v-myc myelocytomatosis viral oncogene homolog (avian) | 0.011 | ||
| DAPK1 | death-associated protein kinase 1 | 0.011 | ||
| AR | androgen receptor | 0.011 | ||
| RFWD2 | ring finger and WD repeat domain 2 | 0.011 | ||
| DVL3 | dishevelled, dsh homolog 3 (Drosophila) | 0.011 | ||
| CCNE1 | cyclin E1 | 0.011 | ||
| GRN | granulin | 0.011 | ||
| POLR3D | polymerase (RNA) III (DNA directed) polypeptide D, 44kDa | 0.011 | ||
| RPL11 | ribosomal protein L11 | 0.011 | ||
| SERPINF2 | serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2 | 0.011 | ||
| NTRK1 | neurotrophic tyrosine kinase, receptor, type 1 | 0.011 | ||
| OTUD4 | OTU domain containing 4 | 0.011 | ||
| FRS2 | fibroblast growth factor receptor substrate 2 | 0.011 | ||
| HNRNPA1 | heterogeneous nuclear ribonucleoprotein A1 | 0.011 | ||
| NFE2L1 | nuclear factor (erythroid-derived 2)-like 1 | 0.011 | Human | |
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.011 | ||
| APOC1 | apolipoprotein C-I | 0.011 | ||
| CCL20 | chemokine (C-C motif) ligand 20 | 0.011 | ||
| EPOR | erythropoietin receptor | 0.011 | ||
| ADAM17 | ADAM metallopeptidase domain 17 | 0.011 | ||
| GTF2I | general transcription factor IIi | 0.010 | ||
| KAT5 | K(lysine) acetyltransferase 5 | 0.010 | ||
| HNRNPC | heterogeneous nuclear ribonucleoprotein C (C1/C2) | 0.010 | ||
| CHPF | chondroitin polymerizing factor | 0.010 | ||
| HPR | haptoglobin-related protein | 0.010 | ||
| RAD23B | RAD23 homolog B (S. cerevisiae) | 0.010 | ||
| SFN | stratifin | 0.010 | ||
| SPOP | speckle-type POZ protein | 0.010 | ||
| TERT | telomerase reverse transcriptase | 0.010 | ||
| FHL1 | four and a half LIM domains 1 | 0.010 | ||
| RARA | retinoic acid receptor, alpha | 0.010 |